Table 6. RT-PCR methods used for tick-borne encephalitis virus RNA detection, external quality assessment for molecular detection of emerging neurotropic viruses, Europe (n = 42 laboratories).
| Target | Method | Number of laboratories | False-negative |
|---|---|---|---|
| Tick-borne encephalitis virus | |||
| TBEV-3'-UTR | Schwaiger et al., 2003 [63]a | 17 | None |
| TBEV-NS1 | Achazi et al., 2011 [64]a | 5 | None |
| TBEV-NS5 | Puchhammer-Stöckl et al., 1995 [65] | 2 | None |
| TBEV-NS4 | Bago et al., 2002 [66]b | 1 | None |
| TBEV-5'-UTR | Schrader et al., 1999 [67] | 1 | None |
| TBEV-E | Briggs et al., 2011 [68] | 1 | None |
| TBEV-E | Gäumann et al., 2010 [69]a | 1 | None |
| TBEV-5'-UTR | Klaus et al., 2010 [70]a | 1 | None |
| TBEV-3'-UTR | Brinkley et al., 2008 [71]b | 1 | None |
| TBEV-E | Andreassen et al., 2012 [72]a | 1 | None |
| TBEV-E | Skarpaas et al., 2006 [73] | 1 | None |
| TBEV-various | Own designb | 2 | None |
| TBEV Unknown | Genesig (commercial)a | 1 | 1 |
| TBEV Unknown | Amplisense (commercial)a | 2 | 1 |
| TBEV Unknown | Viasure (commercial)a | 1 | None |
| Pan-flavivirus | |||
| Pan-flavi NS5 | Scaramozzino et al., 2001 [51] | 7 | None |
| Pan-flavi NS5 | Sanchez-Seco et al., 2005 [52] | 3 | 2 |
| Pan-flavi NS5 | Moureau et al., 2007 [53] | 1 | None |
| Pan-flavi NS5 | Patel et al., 2013 [54] | 2 | None |
| Pan-flavi NS5 | Briese et al., 1999 [55] | 1 | None |
| Pan-flavi NS5 | Vina-Rodriguez et al., 2017 [56] | 1 | None |
| Pan-flavi NS5 | Vazques et al., 2012 [57] | 1 | None |
| Pan-flavi unknown | Own design | 2 | None |
| Pan-flavi unknown | Genekam (commercial) | 1 | None |
| Pan-flavi unknown | TibMolBiol (commercial) | 1 | None |
TBEV: tick-borne encephalitis virus.
a Included in statistical analysis as classified as virus-specific real-time RT-PCR.
b Excluded from statistical analysis since cannot be classified as real-time RT-PCR or conventional RT-PCR.